Darling Ingredients shares rose 4.7% to $60.49 at the latest close. The move came against a filing in which three months of revenue grew 16.4%, but operating income grew more than sixfold, from $75.9 million to $555.2 million.
That is not ordinary sales leverage. Gross margin widened to 29.2% from 23.3%, and net income reached $387.3 million from $12.7 million. The business sold more, but prices and mix did much of the heavy lifting.
Management gave the three-month period a fairly specific explanation:
"The increase was primarily due to increases in fat and protein prices, improved quality and consistency, and increased sales into higher-margin end markets."
Darling Ingredients, 10-Q, August 7, 2026
In plain English, the revenue increase was useful, but the margin change was the event. Feed Ingredients sales rose by $213.0 million, with $209.6 million of that increase attributed to finished product prices. The company’s smaller lines were mixed.
Then there is the item that makes the profit comparison less clean. Darling said operating income also benefited from about $18.5 million of net tariff recoveries, alongside higher sales volumes from increased market demand.
"The increase in operating income was primarily due to the recognition of approximately $18.5 million of net tariff recoveries recorded and an increase in sales volumes due to increased market demand during the three months ended July 4, 2026 that more than offset an increase in selling, general and administrative expenses as compared to the same period of fiscal 2025."
Darling Ingredients, 10-Q, August 7, 2026
The receipt is not that tariffs explain the whole jump. They plainly do not. The point is that tariff-related recoveries helped a period already benefiting from better prices, product quality, end-market mix, and volume. Those are different kinds of improvement, bundled into one very large earnings number.
The cash lines add another layer. Cash ended the period at $160.7 million, up from $94.6 million a year earlier, but cash used in investing activities for the first six months rose to $523.6 million from $159.4 million. Darling attributed the increase to contributions to the DGD Joint Venture, acquisitions, and higher capital expenditures.
That matters because the income statement and the cash ledger are describing different parts of the business at once: sharply higher reported profit, alongside a much larger call on cash for investment. The filing does not say how much of the six-month investing outflow came from each item.
The historical backdrop is similarly uneven. Darling’s latest annual results showed a 4.5% operating margin, versus 32.2% in this latest three-month period. Its current P/E is 154.3x on the supplied annual figures, making the distinction between recurring operating performance and tariff-related recovery unusually visible in the numbers, without settling it.
Darling’s next 10-Q will add the next comparable three-month read on fat and protein prices, higher-margin end markets, tariff recoveries, and investing cash. For now, the filing leaves a simple trade-off: a profit increase, alongside much larger investing cash use.
Darling’s latest three months produced far more profit, while its first six months consumed far more investing cash.